Marc Olivier Perret serves as Executive at Conatus Pharmaceuticals Inc, where they oversee executive responsibilities. Since joining the company, Marc Olivier Perret has executed 5 insider transactions totaling $1.8M, demonstrating a bullish approach to their equity position. Their most recent transaction on Jul 30, 2013 involved exercising options for 1,258,730 shares valued at $0.
Marc Olivier Perret currently holds 1,258,730 shares of Conatus Pharmaceuticals Inc (CNAT), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Marc Olivier Perret has been a net buyer of CNAT stock. They have purchased $1.8M and sold $3.9K worth of shares.
Marc Olivier Perret's most recent insider trade was on Jul 30, 2013, when they sold 1,258,730 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Jul 30, 2013 | CNAT | $3.9K | Sale | 352 | $11.00 | Discretionary |
| Jul 30, 2013 | CNAT | $184.2K | Other | 16,742 | $11.00 | Discretionary |
| Jul 30, 2013 | CNAT | $1.8M | Purchase | 165,525 | $11.00 | Discretionary |